XML 34 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condenced Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Impact of adoption of new accounting standard ASU 2016-16 $ (1,824)       $ (1,824)
Beginning balance (in shares) at Dec. 31, 2017   44,219      
Beginning balance at Dec. 31, 2017 194,451 $ 111 $ 545,953 $ 398 (352,011)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (44,875)     (7,967) (36,908)
Issuance of common stock upon exercise of stock options (in shares)   591      
Issuance of common stock upon exercise of stock options 2,563 $ 1 2,562    
Issuance of common stock under employee stock purchase plan (in shares)   234      
Issuance of common stock under employee stock purchase plan 1,243 $ 1 1,242    
Issuance of common stock for vested restricted stock units (in shares)   916      
Issuance of common stock for vested restricted stock units 0 $ 2 (2)    
Tax withholding related to vesting of restricted stock units (in shares)   (120)      
Tax withholding related to vesting of restricted stock units (747)   (747)    
Stock-based compensation costs 10,363   10,363    
Ending Balance (in shares) at Sep. 30, 2018   45,840      
Ending balance at Sep. 30, 2018 161,174 $ 115 559,371 (7,569) (390,743)
Beginning balance (in shares) at Jun. 30, 2018   44,906      
Beginning balance at Jun. 30, 2018 169,458 $ 112 553,945 (1,981) (382,618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (13,713)     (5,588) (8,125)
Issuance of common stock upon exercise of stock options (in shares)   403      
Issuance of common stock upon exercise of stock options 1,861 $ 1 1,860    
Issuance of common stock under employee stock purchase plan (in shares)   0      
Issuance of common stock under employee stock purchase plan 0 $ 0 0    
Issuance of common stock for vested restricted stock units (in shares)   604      
Issuance of common stock for vested restricted stock units 0 $ 2 (2)    
Tax withholding related to vesting of restricted stock units (in shares)   (73)      
Tax withholding related to vesting of restricted stock units (471)   (471)    
Stock-based compensation costs 4,039   4,039    
Ending Balance (in shares) at Sep. 30, 2018   45,840      
Ending balance at Sep. 30, 2018 161,174 $ 115 559,371 (7,569) (390,743)
Beginning balance (in shares) at Dec. 31, 2018   46,378      
Beginning balance at Dec. 31, 2018 160,240 $ 116 564,722 (7,126) (397,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (22,613)     (3,468) (19,145)
Offering costs (46)   (46)    
Issuance of common stock in exchange for research and development services (in shares)   276      
Issuance of common stock in exchange for research and development services 1,500 $ 1 1,499    
Issuance of common stock upon exercise of stock options (in shares)   265      
Issuance of common stock upon exercise of stock options 969   969    
Issuance of common stock under employee stock purchase plan (in shares)   254      
Issuance of common stock under employee stock purchase plan 1,235 $ 1 1,234    
Issuance of common stock for vested restricted stock units (in shares)   996      
Issuance of common stock for vested restricted stock units 0 $ 2 (2)    
Tax withholding related to vesting of restricted stock units (in shares)   (152)      
Tax withholding related to vesting of restricted stock units (705)   (705)    
Stock-based compensation costs 9,417   9,417    
Ending Balance (in shares) at Sep. 30, 2019   48,017      
Ending balance at Sep. 30, 2019 149,997 $ 120 577,088 (10,594) (416,617)
Beginning balance (in shares) at Jun. 30, 2019   47,152      
Beginning balance at Jun. 30, 2019 147,984 $ 118 572,734 (5,979) (418,889)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (2,343)     (4,615) 2,272
Offering costs (46)   (46)    
Issuance of common stock in exchange for research and development services (in shares)   276      
Issuance of common stock in exchange for research and development services 1,500 $ 1 1,499    
Issuance of common stock upon exercise of stock options (in shares)   98      
Issuance of common stock upon exercise of stock options 397   397    
Issuance of common stock under employee stock purchase plan (in shares)   0      
Issuance of common stock under employee stock purchase plan 0 $ 0 0    
Issuance of common stock for vested restricted stock units (in shares)   573      
Issuance of common stock for vested restricted stock units 0 $ 1 (1)    
Tax withholding related to vesting of restricted stock units (in shares)   (82)      
Tax withholding related to vesting of restricted stock units (378)   (378)    
Stock-based compensation costs 2,883   2,883    
Ending Balance (in shares) at Sep. 30, 2019   48,017      
Ending balance at Sep. 30, 2019 $ 149,997 $ 120 $ 577,088 $ (10,594) $ (416,617)